Mark Gelfand
Founder at Cibiem, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard R. Levin | M | - |
Coridea LLC
 Coridea LLC Medical SpecialtiesHealth Technology Coridea LLC develops and manufactures medical devices. The firm provides treatment for diastolic heart failure, refractory angina and end-stage renal diseases. The company was founded by Mark Gelfland and Howard R. Levin in 2003 and is headquartered in New York, NY.
Cibiem, Inc.
 Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA.
Axon Therapies, Inc.
 Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | 21 years |
| Paul LaViolette | M | 66 |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY.
Cibiem, Inc.
Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | - |
| Kenneth Martin | M | - |
Cibiem, Inc.
Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | 11 years |
| Farhad Khosravi | M | - |
Cibiem, Inc.
Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | - |
| Michael Buck | M | - |
Cibiem, Inc.
Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | - |
| William Hank Kucheman | M | 74 |
Cibiem, Inc.
Cibiem, Inc. Medical SpecialtiesHealth Technology Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA. | 7 years |
| Brian E. Farley | M | 66 |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | 2 years |
| Richard S. Walsh | M | - |
Corvent Medical, Inc.
 Corvent Medical, Inc. Medical/Nursing ServicesHealth Services Corvent Medical, Inc. engages in developing smart, versatile, lifesaving ventilators for critical care. Its product is CorVent single-use ventilator. The company is headquartered in New York, NY. | 4 years |
| Steve Hochberg | M | 62 |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | - |
| Chris H. Colecchi | M | - |
Coridea LLC
Coridea LLC Medical SpecialtiesHealth Technology Coridea LLC develops and manufactures medical devices. The firm provides treatment for diastolic heart failure, refractory angina and end-stage renal diseases. The company was founded by Mark Gelfland and Howard R. Levin in 2003 and is headquartered in New York, NY. | - |
| Andrew ElBardissi | M | 42 |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | - |
| Imran Eba | M | - |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | 10 years |
| Imran Eba | M | - |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | - |
| Suraj Mudichintala | M | - |
Axon Therapies, Inc.
Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | - |
| Gregg L Semenza | M | - |
The Johns Hopkins University School of Medicine
| 34 years |
| Jeremy Nelson | M | - |
Corvent Medical, Inc.
Corvent Medical, Inc. Medical/Nursing ServicesHealth Services Corvent Medical, Inc. engages in developing smart, versatile, lifesaving ventilators for critical care. Its product is CorVent single-use ventilator. The company is headquartered in New York, NY. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Ehlers | M | - |
The Johns Hopkins University School of Medicine
| 7 years |
| Eric Rowinsky | M | 67 |
The Johns Hopkins University School of Medicine
| 8 years |
| Karen B. Chapman | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Gary Romano | M | 63 |
The Johns Hopkins University School of Medicine
| 1 years |
| Fayez Hamzeh | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Scott Brun | M | 56 |
The Johns Hopkins University School of Medicine
| 4 years |
| Anil Sethi | M | - |
The Johns Hopkins University School of Medicine
| 2 years |
| June Lee | M | 58 |
The Johns Hopkins University School of Medicine
| 4 years |
| Timothy M. Wright | M | 69 |
The Johns Hopkins University School of Medicine
| 8 years |
| Raymond Pratt | M | 73 |
The Johns Hopkins University School of Medicine
| 4 years |
| David J. Kim | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Peter Pronovost | M | 59 |
The Johns Hopkins University School of Medicine
| 4 years |
| John Niederhuber | M | 85 |
The Johns Hopkins University School of Medicine
| 4 years |
| John H. Vernachio | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Yigong Shi | M | 57 |
The Johns Hopkins University School of Medicine
| 3 years |
| Hyam Levitsky | M | 66 |
The Johns Hopkins University School of Medicine
| - |
| Michael Kauffman | M | 60 |
The Johns Hopkins University School of Medicine
| 7 years |
| Robert Avery | M | - |
The Johns Hopkins University School of Medicine
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Gelfand
- Personal Network
